Dermovate Cream 0.05% (Clobetasol)
Scheriproct ointment. Aluminium tubes containing 10 g and 30 g of colourless to slightly yellow translucent ointment. Scheriproct suppositories. Boxes containing an aluminium laminated strip pack of 6 or 12 yellowish-white suppositories. Special Precautions for Disposal. Nov 18, · Scheriproct Ointment - Patient Information Leaflet (PIL) by Karo Pharma AB.
Aspirin is used to relieve pain such as headache, toothache and period pain, also used to treat scheriproch and 'flu-like' symptoms and reduce fever. Paracetamol belongs to a group of medicines known as analgesics, or painkillers. It is used to relieve mild to moderate pain.
Acheriproct is another word for fat. Lipids are easily stored in your body and serve as a source of energy. If you have an underactive thyroid gland what is the meaning of religious education may be prescribed Levothyroxine Eltroxin.
Simvastatin is used for lowering cholesterol and other lipids in the blood; to reduce the risk scheeriproct heart and blood vessel disease. Amlodipine is given to treat hypertension high blood pressure. It is also taken to help prevent angina chest pain. Featured medicine directory pages. Read this clinical article. Atorvastatin tablets Lipid is another word for fat. Levothyroxine If you have an sccheriproct thyroid gland you may be prescribed Levothyroxine Eltroxin.
Simvastatin Simvastatin is used for lowering cholesterol and other lipids in the blood; to reduce the risk of heart and blood vessel disease. Amlodipine tablets Istin Amlodipine is given to treat hypertension high blood pressure. Featured Breathing Treatment and Respiratory Care. Featured Cancer Treatment and Drugs. Featured Diabetes Medicines. Featured Fertility Treatment and Contraceptives.
Featured Substance Abuse Treatment.
How likely is it that you would recommend our site to a friend?
Scheriproct N Cream; Scheriproct N Suppositories; Doproct Suppository (3 Boxes/ 30 Units) Acne & Anti – Aging. Retin-A. Retin-A % (Tretinoin) 10g; Retin-A % (Tretinoin) 10g or 20g; Hydroquinone; Epiduo Gel % / %; Differin Gel % (Aldapene) Metronidazol Robaz %; Benzac AC % or 5% (Benzoyl Peroxide) Skinoren Cream 20%. Dermovate cream and ointment both contain the active ingredient clobetasol propionate, which is a type of medicine called a topical corticosteroid. Corticosteroids (also known as steroids) are medicines used for reducing inflammation. Glyceryl trinitrate ointment after the procedure helps both with pain and with healing. Doppler-guided transanal hemorrhoidal dearterialization is a minimally invasive treatment using an ultrasound Doppler to accurately locate the arterial blood inflow. These arteries are then "tied off" and the prolapsed tissue is sutured back to its normal.
Please read this leaflet carefully before you start using Scheriproct Ointment and Suppositories. It does not contain all the available information. The active ingredients reduce the inflammation and pain associated with such problems.
If you use it after the expiry date has passed, it may not work as well. Talk to your doctor or pharmacist, if you require more information. Tell your doctor if you are using other creams, ointments or suppositories for this problem. This includes any that you buy without a prescription from a pharmacy, supermarket or health food shop. Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine. Follow carefully all directions given to you by your doctor or pharmacist.
They may differ from the information contained in this leaflet. If you do not understand the instructions in this leaflet, ask your doctor or pharmacist for help. Ointment should be applied twice daily. Application up to four times on the first day may provide faster initial relief. Smear a small amount of ointment about the size of a pea around the anus and just inside the anus using your finger. The nozzle supplied with the tube should be screwed on to the tube, and used to apply the ointment internally.
If the anus if very inflamed and painful, it is advisable to gently apply the ointment internally with your finger. Check the hardness of the suppository before unwrapping it. If it is soft, place the wrapped suppository in cold water before use. This will ensure that the suppository maintains its shape when it is used. Unless otherwise advised by your doctor, one suppository should be unwrapped and inserted high into the back passage daily.
For severe symptoms, one suppository may be inserted two to three times on the first day. Treatment should continue for one week, less frequently ointment once a day or one suppository every other day after symptoms have cleared.
The length of treatment should however, not exceed four weeks. Do not try to make up for the amount you missed by using more than you would normally use. If you have trouble remembering to use your medicine, ask your doctor or pharmacist for some hints. Otherwise your doctor may think that it was not effective and change your treatment unnecessarily. If you use large amounts for a long time, the chance of absorption through the skin and the chance of side effects increases.
A locked cupboard at least one and a half metres above the ground is a good place to store medicines. Do not freeze. They should not be used after the expiry date printed on the outer box, base of the tube or on the suppository foil.
The active ingredients of Scheriproct are synthetic corticosteroids, prednisolone hexanoate and cinchocaine hydrochloride. Scheriproct 1 g ointment contains 1. Scheriproct suppository, 1 suppository contains 1.
Excipients with known effect. Contains benzoates. For the full list of excipients, see Section 6. Scheriproct ointment. Colourless to slightly yellow translucent ointment. Scheriproct suppositories. Yellowish-white suppositories. Symptomatic relief of pain and irritation associated with haemorrhoids, superficial anal fissures and proctitis.
The anal region should be cleaned thoroughly before using Scheriproct, which is best applied after defecation. There is usually a rapid improvement, but this should not mislead one into stopping treatment too soon. To avoid relapses, Scheriproct should be continued for at least one week, though less frequently ointment once a day or one suppository every other day , even when the symptoms have completely disappeared.
However, duration of treatment should, as far as possible, not exceed 4 weeks. Unless otherwise prescribed by the doctor, generally, apply twice daily, on the first day, for faster symptomatic relief, up to four times.
Smear a little ointment about the size of a pea around the anus and in the anal ring with a finger and use the fingertip to overcome the resistance of the sphincter. Before applying within the rectum, the enclosed nozzle should be screwed on to the tube. However, for very inflamed and hence painful lesions, it is advisable initially to apply the ointment internally with the finger.
Protruding lumps should be thickly smeared and carefully pressed back with the finger. In general, insert one suppository daily high into the rectum.
If symptoms are severe, insert one suppository two to three times on the first day. The consistency of suppositories that have become soft due to warmth should be restored by placing them in cold water before the covering is removed. Tuberculous or syphilitic processes in the area to be treated. Virus diseases e. Hypersensitivity to individual components. Traumatised skin. Local infections where concomitant therapy is not in place see Section 4. Additional specific therapy is required in fungal, bacterial, virus infections.
Inadvertent contact of the preparation with the eyes should be avoided. Careful hand washing after use is recommended. Prolonged use leads to atrophy. Systemic absorption may be increased when there is local trauma or prolonged use. The excipient s in Scheriproct ointment and suppository may reduce the effectiveness of latex products such as condoms.
Scheriproct contains castor oil, which can cause skin reactions. Visual disturbance. Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy CSCR which have been reported after use of systemic and topical corticosteroids.
Use in the elderly. No data available. Paediatric use. Effects on laboratory tests. No interaction studies have been performed. Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side-effects, including adrenal suppression.
The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, and patients should be monitored accordingly. Effects on fertility. No animal studies have investigated the potential of prednisolone hexanoate or cinchocaine hydrochloride to impair fertility. Category A Epidemiological studies suggest that there could possibly be an increased risk of oral clefts among newborns of women who were treated with glucocorticosteroids during the first trimester of pregnancy.
No animal studies have investigated the teratogenic potential of any of the active substances in Scheriproct. Since epidemiological studies have as yet given no indications of teratogenicity due to systemic glucocorticoid therapy, no teratogenic effects are to be expected from the glucocorticoids in Scheriproct under therapeutic conditions. However, taking animal experimental results into consideration, particular care should be taken when prescribing Scheriproct during pregnancy.
As a general rule, topical preparations containing glucocorticoids should not be applied during the first trimester of pregnancy. The clinical indication for treatment with Scheriproct must be carefully reviewed and the benefits weighed against the risks in pregnant women.
In particular, prolonged use must be avoided. There is insufficient information on the excretion of prednisolone hexanoate and cinchocaine hydrochloride in human milk. The clinical indication for treatment with Scheriproct must be carefully reviewed and the benefits weighed against the risks in lactating women. The effects of this medicine on a person's ability to drive and use machines were not assessed as part of its registration.
If Scheriproct is applied for long periods of time more than 4 weeks , local concomitant symptoms, such as atrophy of the skin, cannot be excluded. Allergic skin reactions may occur in rare cases. Post marketing. Eye disorders. Reporting suspected adverse effects. Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions at www. In the case of accidental oral intake of the preparation e. For information on the management of overdose, contact the Poisons Information Centre on Australia. Mechanism of action. Prednisolone exerts an anti-inflammatory, anti-allergic and anti-pruritic effect.